Gambro Ab

Fresenius Medical Care Deutschland Gmbh

Gambro Lundia Ab

Per Kjellstrand

Anders Wieslander

Ola Carlsson

Lennart Jönsson

Eddie Nilsson

Sven A Jonsson

Magnus Braide

Sten-Börje Lindqvist

Ellinor Broms

Anders Andren

Eva Svensson

Torbjörn LINDÉN

The present invention concerns a peritoneal dialysis fluid with enhanced ultrafiltration during the dialysis dwell period. According to the present invention this is achieved by a peritoneal dialysis fluid comprising sodium ions, osmotic agent and a buffer, characterised in that it comprises citrate at a level of 4 to 10 mM in a final solution ready for use.

Peritoneal dialysis fluid

The invention refers to a medical system comprising a first subsystem with a first connection portion (), and a second subsystem with a second connection portion (). The invention also refers to a device and a method for connecting the subsystems to each other. One of the subsystems contains a fluid. The connecting device is adapted to connect the subsystems to each other to permit transport of the fluid from one of the subsystems to the other subsystem. The device comprises a container () enclosing an inner space. A substantially sterile atmosphere is provided in the inner space. The container receives the first connection portion and the second connection portion in the inner space. A mechanism is provided for connecting, from outside the container, the first connection portion and the second connection portion to each other in the inner space.

Connecting device, a medical system, and a method of connecting medical subsystems

Methods and apparatus are disclosed for reducing the degradation of heat sensitive components contained in a medical substance during heat sterilization of a heat sterilizable container including a first chamber including a first amount of a first medical substance and a second chamber including a second amount of a second medical substance, the first amount being greater than the second amount. The method includes heating the heat sterilizable container to a first predetermined temperature for sterilizing the first and second medical substances, thermally insulating the second chamber during at least a portion of the heating of the heat sterilizable container to the first predetermined temperature, holding the heat sterilizable container at the first predetermined temperature for a first predetermined time period, and cooling the heat sterilizable container thereafter.

Method and apparatus for reducing the degradation of heat sensitive components in medical substances during heat sterilization

System employing a sterile medical solution containing glucose or

Growing community of inventors

Södra Sandby, Sweden

Per Kjellstrand